// App-Quantinova.ai

AB0215 (2021) : COMPARISON BETWEEN RITUXIMAB ORIGINATOR THERAPY AND ITS BIOSIMILAR IN THE INCIDENCE OF LATE-ONSET NEUTROPENIA IN ADULT PATIENTS WITH RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISEASES

Researchers

Presenter

  • M. M. Ahmad

Principal Investigators

  • N/A

Medical Centers

  • Western General Hospital, Edinburgh, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Genetic Disorder

Disease

  • Rheumatoid arthritis

  • Neutropenia

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Roche

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved